COX-2 inhibition reverses leptin-stimulated breast cancer growth in vitro

被引:0
|
作者
Somasundar, P
Vona-Davis, LC
Riggs, D
Jackson, B
McFadden, DW
机构
关键词
D O I
10.1016/S0016-5085(03)83096-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A611 / A611
页数:1
相关论文
共 50 条
  • [31] GROWTH ADVANTAGE OF COX-2 EXPRESSING PANCREATIC CANCER CELLS IN VITRO AND IN VIVO
    Li, A.
    Hasan, S.
    Angst, E.
    Park, J.
    Reber, H. A.
    Hines, O. J.
    Eibl, G.
    PANCREAS, 2008, 37 (04) : 480 - 480
  • [32] Effects of COX-2 inhibition on stimulated renin system in man.
    Kammerl, MC
    Lohmaier, R
    Kruger, B
    Stubanus, M
    Fischereder, M
    Kramer, BK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 735A - 735A
  • [33] Molecular effects of cyclooxygenase-2 (Cox-2) inhibition in primary breast cancer in vivo
    Betambeau, N
    Davies, G
    Sacks, N
    Gui, G
    MacNeill, F
    Ebbs, S
    Dowsett, M
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S240 - S240
  • [35] COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro
    Du, Ye
    Shi, Aiping
    Han, Bing
    Li, Sijie
    Wu, Di
    Jia, Hongyao
    Zheng, Chao
    Ren, Liqun
    Fan, Zhimin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (04) : 1385 - 1393
  • [36] COX-2 INHIBITION IN THE ADJUVANT SETTING FOR COLORECTAL CANCER
    Kerr, D. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 37 - 37
  • [37] Leptin-stimulated inhibition of mitochondrial permeability transition is dependent on presence of functional OB-RB leptin receptor
    Dixon, Richard A.
    Smith, Christopher C. T.
    Davidson, Sean M.
    Yellon, Derek M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (04) : 782 - 782
  • [38] Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
    Anderson, GD
    Hauser, SD
    McGarity, KL
    Bremer, ME
    Isakson, PC
    Gregory, SA
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11): : 2672 - 2679
  • [39] Overexpression of COX-2 in oral cancer: COX-2-dependent and -independent growth inhibition by NS398
    Hague, A
    Minter, HA
    Elder, DJE
    Huntley, S
    Eveson, JW
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1227S - 1227S
  • [40] Colon cancer cell growth inhibition by treatment with a selective COX-2 inhibitor.
    Goldman, AP
    Williams, CS
    Williams, VP
    DuBois, RN
    GASTROENTEROLOGY, 1998, 114 (04) : A601 - A601